Scientific Opinion on the safety of ‘heat-treated milk products fermented with Bacteroides xylanisolvens DSM 23964’ as a novel food

EFSA Journal

Volumn 13, Issue 1, 2015, Pages

[No Author Info available]

Author keywords

Bacteroides xylanisolvens; dairy; fermentation; novel food

Indexed keywords

EID: 85063273929     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2015.3956     Document Type: Article

References (32)

1. Andersson I and Oete R, 1994. Nutritional quality of pasteurised milk. Vitamin B12, folate and ascorbic acid content during storage. International Dairy Journal, 4, 161–172.
2. BAuA (Bundesanstalt für Arbeitsschutz und Arbeitsmedizin), 2011. Ausschuss für Biologische Arbeitsstoffe (ABAS) Unterausschuss 3. Einstufung der Spezies Bacteroides xylanisolvens und des Stammes Bacteroides xylanisolvens (Bacteroides ovatus) CTC1 in eine Risikogruppe.
3. Brook I, 1989. Pathogenicity of the Bacteroides fragilis group. Annals of Clinical Laboratory Science, 19, 360–376.
4. Chassard C, Delmas E, Lawson PA and Bernalier-Donadille A, 2008. Bacteroides xylanisolvens sp. nov., a xylan-degrading bacterium isolated from human faeces. International Journal of Systemic and Evolution Microbiology, 58, 1008–1013.
5. Culebras E, Rodriguez-Avial I, Betriu C, Gómez C and Picazo JJ, 2012. Rapid identification of clinical isolates of Bacteroides species by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anaerobe, 18, 163–165.
6. Deutsche Gesetzliche Unfallversicherung (2010). Riegel HJ, 2010. Letter of DGUV to Dr Philippe Ulsemer, dated 10 September 2010.
7. DSMZ (German Resource Centre for Biological Material), 2010. Letter of DSMZ GmbH to Glycotope GmbH, dated 6 September 2010.
8. EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards), 2014. Statement on the update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 1: Suitability of taxonomic units notified to EFSA until October 2014. EFSA Journal 2014;12 (12):3938, 18 pp. doi:10.2903/j.efsa.2014.3938.
9. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014. Scientific Opinion on the evaluation of allergenic foods and food ingredients for labelling purposes. EFSA Journal 2014;12 (11):3894, 286 pp. doi:10.2903/j.efsa.2014.3894.
10. Eitel Z, Sóki J, Urbán E, Nagy E, and the ESCMID Study Group on Anaerobic Infection, 2013. The prevalence of antibiotic resistance genes in Bacteroides fragilis group strains isolated in different European countries. Anaerobe, 21, 43–49. doi: 10.1016/j.anaerobe.2013.03.001.
11. nd edition. Codex Standard for fermented milks, p. 6. Available online: http://www.fao.org per dayocrep/015/i2085e/i2085e00.pdf.
12. Finegold SM, Sutter VL and Mathisen GE, 1983. Normal indigenous intestinal flora. In: Human intestinal microflora in health and disease. Ed. Hentges DJ. Academic Press, New York, USA, 3–32.
13. Finot PA, Deutsch R and Bujard E, 1981. The extent of the Maillard reaction during the processing of milk. Progress in Food and Nutrition Sciences, 5, 345–355.
14. Gliquem H and Birlouez-Aragon J, 2005. Effects of sterilization, packaging and storage on vitamin C degradation, protein denaturation and glycation in fortified milks. Journal of Dairy Science, 88, 891–899.
15. Kulagina EV, Efimov BA, Maximov PY, Kafarskaia LI, Chaplin AV and Shkoporov AN, 2012. Species composition of Bacteroidales order bacteria in the feces of healthy people of various ages. Bioscience, Biotechnology and Biochemistry, 76, 167–171.
16. Leuschner J, 2010a. Mutagenicity study of Bacteroides xylanisolvens CTC1 in the Salmonella typhimurium reverse mutation assay (in vitro). LPT Report No 22355, 26 August 2010. Unpublished report of the Laboratory of Pharmacology and Toxicology, Hamburg, Germany.
17. Leuschner J, 2010b. In vitro assessment of the clastogenic activity of Bacteroides xylanisolvens in cultured human peripheral lymphocytes. LPT Report No 22356 dated 26 August 2010. Unpublished report of the Laboratory of Pharmacology and Toxicology, Hamburg, Germany.
18. Leuschner J, 2010c. Repeated dose 90-day oral toxicity study of Bacteroides xylanisolvens CTC-1 in mice. LPT Report No 22171 dated 23 September 2010. Unpublished report of the Laboratory of Pharmacology and Toxicology, Hamburg, Germany.
19. Marconi E and Panfili G, 1998. Chemical composition and nutritional properties of commercial products of mare milk powder. Journal of Food Composition and Analysis, 11, 178–187.
20. Marschal M, Schumacher U and Autenrieth I, 2011. Improvement of identification of anaerobes by MALDI-TOF mass spectrometry analysis. Proceedings of the 21st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 27th International Congress of Chemotherapy (ICC), Milan, Italy. 9 May 2011.
21. Ponnusamy K, Choi JN, Kim J, Lee SY and Lee CH, 2011. Microbial community and metabolomic comparison of irritable bowel syndrome feces. Journal of Medical Microbiology, 60, 817–827.
22. Salyers A, 1984. Bacteroides of the human lower intestinal tract. Annual Reviews of Microbiology, 38, 293–313.
23. Sanchez E, Laparra JM and Sanz Y, 2012. Discerning the role of Bacteroides fragilis in celiac disease pathogenesis. Applied and Environmental Microbiology, 78, 6507–6515. doi: 10.1128/AEM.00563-12.
24. Toutounian K, 2008. Pasteurization of fermented milk product produced with B. xylanisolvens DSM 23964. Internal Report of Avitop GmbH, dated 28 September 2008.
25. Toutotunian K, 2010. Investigation of the in-vivo pathogenicity of Bacteroides xylanisolvens CTC-1 (abscess formation). Internal Report of Avitop GmbH, dated 19 August 2010.
26. Ulsemer P, Toutounian K, Schmidt J, Karsten U and Goletz S, 2012a. Preliminary safety evaluation of a new Bacteroides xylanisolvens isolate. Applied and Environmental Microbiology, 78, 528–535.
27. Ulsemer P, Toutounian K, Schmidt J, Leuschner J, Karsten U and Goletz S, 2012b. Safety assessment of the commensal strain Bacteroides xylanisolvens DSM 23964. Regulatory Toxicology and Pharmacology, 62, 336–346.
28. Ulsemer P, Toutounian K, Kressel G, Schmidt J, Karsten U, Hahn A and Goletz S, 2012c. Safety and tolerance of Bacteroides xylanisolvens DSM 23964 in healthy adults. Beneficial Microbes, 3, 99–111.
29. Van Boekel MAJS, 1998. Effect of heating on Maillard reactions in milk. Food Chemistry, 62, 403–414.
30. Wexler HM, 2007. Bacteroides: the good, the bad, and the nitty-gritty. Clinical Microbiology Reviews, 20, 593–621.
31. Wijesinha-Bettoni R and Burlingame B, 2013. Milk and dairy product composition. In: Milk and dairy products in human nutrition. Eds Muelhoff E, Bennett A and McMahon. FAO, Rome, 41–102.
32. Zitomersky NL, Coyne MJ and Comstock LE, 2011. Longitudinal analysis of the prevalence, maintenance and IgA response to species of the order Bacteroidales in the human gut. Infection and Immunity, 79, 2012–2020.